カテゴリー： LP Information, 世界, 医療/バイオ

世界の侵襲性真菌症（IFD）感染診断試薬市場予測 2021年-2026年

【英語タイトル】Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9649）・商品コード：LPI21MY9649
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：137
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「侵襲性真菌症（IFD）感染診断試薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、（1,3）-β-D-グルカン検出（G実験）試薬、ガラクトマンナンテスト（GM実験）試薬など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。侵襲性真菌症（IFD）感染診断試薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・侵襲性真菌症（IFD）感染診断試薬の世界市場概要（サマリー）
・侵襲性真菌症（IFD）感染診断試薬の企業別販売量・売上
・侵襲性真菌症（IFD）感染診断試薬の企業別市場シェア
・侵襲性真菌症（IFD）感染診断試薬の世界市場規模 2016年-2021年：種類別（（1,3）-β-D-グルカン検出（G実験）試薬、ガラクトマンナンテスト（GM実験）試薬）
・侵襲性真菌症（IFD）感染診断試薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他）
・侵襲性真菌症（IFD）感染診断試薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・侵襲性真菌症（IFD）感染診断試薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・侵襲性真菌症（IFD）感染診断試薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・侵襲性真菌症（IFD）感染診断試薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・侵襲性真菌症（IFD）感染診断試薬市場の成長要因・課題・動向
・侵襲性真菌症（IFD）感染診断試薬の世界市場予測 2021年-2026年
・侵襲性真菌症（IFD）感染診断試薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・侵襲性真菌症（IFD）感染診断試薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・侵襲性真菌症（IFD）感染診断試薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・侵襲性真菌症（IFD）感染診断試薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・侵襲性真菌症（IFD）感染診断試薬の世界市場予測：種類別（（1,3）-β-D-グルカン検出（G実験）試薬、ガラクトマンナンテスト（GM実験）試薬）
・侵襲性真菌症（IFD）感染診断試薬の世界市場予測：用途別（病院、研究室、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent will have significant change from previous year. By the most conservative estimates of global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
(1,3)-β-D-glucan detection (G experimental) Reagent
Galactomannan Test (GM experimental) Reagent

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Laboratory
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Associates of Cape Cod Inc
Dynamiker Biotechnology (Tianjin) Co., Ltd.
IMMY
Gold Mountainriver
BioRad
Zhanjiang A & C Biological Ltd.
Institut VirionSerion GmbH

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumption 2016-2026
2.1.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumption CAGR by Region
2.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Type
2.2.1 (1,3)-β-D-glucan detection (G experimental) Reagent
2.2.2 Galactomannan Test (GM experimental) Reagent
2.3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type
2.3.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
2.3.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Market Share by Type (2016-2021)
2.3.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Type (2016-2021)
2.4 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application
2.5.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Market Share by Application (2016-2021)
2.5.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Market Share by Application (2016-2021)
2.5.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Application (2016-2021)

3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Company
3.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Company
3.1.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Company (2019-2021)
3.1.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Company (2019-2021)
3.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Company
3.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Company (2019-2021)
3.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Company (2019-2021)
3.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Company
3.4 Global Manufacturers Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Location Distribution
3.4.2 Players Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Region
4.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Region
4.1.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region
4.1.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region
4.2 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Growth
4.3 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Growth
4.4 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Growth
4.5 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Growth

5 Americas
5.1 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country
5.1.1 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021)
5.1.2 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021)
5.2 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type
5.3 Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region
6.1.1 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region (2016-2021)
6.1.2 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (2016-2021)
6.2 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type
6.3 APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Country
7.1.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021)
7.1.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021)
7.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type
7.3 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Country
8.1.1 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021)
8.1.2 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021)
8.2 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type
8.3 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Distributors
10.3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Customer

11 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Forecast
11.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Forecast by Region
11.1.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Forecast by Regions (2021-2026)
11.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Forecast by Type
11.7 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Forecast by Application

12 Key Players Analysis
12.1 Associates of Cape Cod Inc
12.1.1 Associates of Cape Cod Inc Associates of Cape Cod Inc Company Information
12.1.2 Associates of Cape Cod Inc Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.1.3 Associates of Cape Cod Inc Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Associates of Cape Cod Inc Main Business Overview
12.1.5 Associates of Cape Cod Inc Latest Developments
12.2 Dynamiker Biotechnology (Tianjin) Co., Ltd.
12.2.1 Dynamiker Biotechnology (Tianjin) Co., Ltd. Company Information
12.2.2 Dynamiker Biotechnology (Tianjin) Co., Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.2.3 Dynamiker Biotechnology (Tianjin) Co., Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Dynamiker Biotechnology (Tianjin) Co., Ltd. Main Business Overview
12.2.5 Dynamiker Biotechnology (Tianjin) Co., Ltd. Latest Developments
12.3 IMMY
12.3.1 IMMY Company Information
12.3.2 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.3.3 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 IMMY Main Business Overview
12.3.5 IMMY Latest Developments
12.4 Gold Mountainriver
12.4.1 Gold Mountainriver Company Information
12.4.2 Gold Mountainriver Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.4.3 Gold Mountainriver Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Gold Mountainriver Main Business Overview
12.4.5 Gold Mountainriver Latest Developments
12.5 BioRad
12.5.1 BioRad Company Information
12.5.2 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.5.3 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BioRad Main Business Overview
12.5.5 BioRad Latest Developments
12.6 Zhanjiang A & C Biological Ltd.
12.6.1 Zhanjiang A & C Biological Ltd. Company Information
12.6.2 Zhanjiang A & C Biological Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.6.3 Zhanjiang A & C Biological Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zhanjiang A & C Biological Ltd. Main Business Overview
12.6.5 Zhanjiang A & C Biological Ltd. Latest Developments
12.7 Institut VirionSerion GmbH
12.7.1 Institut VirionSerion GmbH Company Information
12.7.2 Institut VirionSerion GmbH Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
12.7.3 Institut VirionSerion GmbH Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Institut VirionSerion GmbH Main Business Overview
12.7.5 Institut VirionSerion GmbH Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of (1,3)-β-D-glucan detection (G experimental) Reagent
Table 3. Major Players of Galactomannan Test (GM experimental) Reagent
Table 4. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type (2016-2021) & (K Units)
Table 5. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
Table 6. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Type (2016-2021) & ($ million)
Table 7. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Type (2016-2021)
Table 8. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Type (2016-2021)
Table 9. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application (2016-2021) & (K Units)
Table 10. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Table 11. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Value by Application (2016-2021)
Table 12. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application (2016-2021)
Table 13. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Application (2016-2021)
Table 14. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Company (2019-2021) & (K Units)
Table 15. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Company (2019-2021)
Table 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Company (2019-2021)
Table 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Producing Area Distribution and Sales Area
Table 20. Players Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Products Offered
Table 21. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region (2016-2021) (K Units)
Table 25. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Region (2016-2021)
Table 26. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Region (2016-2021)
Table 28. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021) & (K Units)
Table 29. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country (2016-2021)
Table 30. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country (2016-2021)
Table 32. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type (2016-2021) & (K Units)
Table 33. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
Table 34. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application (2016-2021) & (K Units)
Table 35. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Table 36. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region (2016-2021) & (K Units)
Table 37. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Region (2016-2021)
Table 38. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Region (2016-2021)
Table 40. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type (2016-2021) & (K Units)
Table 41. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
Table 42. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application (2016-2021) & (K Units)
Table 43. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Table 44. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021) & (K Units)
Table 45. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country (2016-2021)
Table 46. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country (2016-2021)
Table 48. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type (2016-2021) & (K Units)
Table 49. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
Table 50. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application (2016-2021) & (K Units)
Table 51. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Table 60. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share Forecast by Application (2021-2026)
Table 68. Associates of Cape Cod Inc Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 69. Associates of Cape Cod Inc Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 70. Associates of Cape Cod Inc Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 71. Associates of Cape Cod Inc Main Business
Table 72. Associates of Cape Cod Inc Latest Developments
Table 73. Dynamiker Biotechnology (Tianjin) Co., Ltd. Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 74. Dynamiker Biotechnology (Tianjin) Co., Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 75. Dynamiker Biotechnology (Tianjin) Co., Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 76. Dynamiker Biotechnology (Tianjin) Co., Ltd. Main Business
Table 77. Dynamiker Biotechnology (Tianjin) Co., Ltd. Latest Developments
Table 78. IMMY Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 79. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 80. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 81. IMMY Main Business
Table 82. IMMY Latest Developments
Table 83. Gold Mountainriver Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 84. Gold Mountainriver Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 85. Gold Mountainriver Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 86. Gold Mountainriver Main Business
Table 87. Gold Mountainriver Latest Developments
Table 88. BioRad Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 89. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 90. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. BioRad Main Business
Table 92. BioRad Latest Developments
Table 93. Zhanjiang A & C Biological Ltd. Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhanjiang A & C Biological Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 95. Zhanjiang A & C Biological Ltd. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Zhanjiang A & C Biological Ltd. Main Business
Table 97. Zhanjiang A & C Biological Ltd. Latest Developments
Table 98. Institut VirionSerion GmbH Basic Information, Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Manufacturing Base, Sales Area and Its Competitors
Table 99. Institut VirionSerion GmbH Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Offered
Table 100. Institut VirionSerion GmbH Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Institut VirionSerion GmbH Main Business
Table 102. Institut VirionSerion GmbH Latest Developments
List of Figures
Figure 1. Picture of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent
Figure 2. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of (1,3)-β-D-glucan detection (G experimental) Reagent
Figure 10. Product Picture of Galactomannan Test (GM experimental) Reagent
Figure 11. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type in 2020
Figure 12. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Type (2016-2021)
Figure 13. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumed in Hospital
Figure 14. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market: Hospital (2016-2021) & (K Units)
Figure 15. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumed in Laboratory
Figure 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market: Laboratory (2016-2021) & (K Units)
Figure 17. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Consumed in Others
Figure 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market: Others (2016-2021) & (K Units)
Figure 19. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application (2016-2021)
Figure 20. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Application in 2020
Figure 21. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Company in 2020
Figure 23. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Regions (2016-2021)
Figure 24. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Region in 2020
Figure 25. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales 2016-2021 (K Units)
Figure 26. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue 2016-2021 ($ Millions)
Figure 27. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales 2016-2021 (K Units)
Figure 28. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue 2016-2021 ($ Millions)
Figure 29. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales 2016-2021 (K Units)
Figure 30. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue 2016-2021 ($ Millions)
Figure 33. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country in 2020
Figure 34. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country in 2020
Figure 35. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type in 2020
Figure 36. Americas Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application in 2020
Figure 37. United States Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Region in 2020
Figure 42. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Regions in 2020
Figure 43. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type in 2020
Figure 44. APAC Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application in 2020
Figure 45. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country in 2020
Figure 52. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country in 2020
Figure 53. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type in 2020
Figure 54. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application in 2020
Figure 55. Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Market Share by Application in 2020
Figure 64. Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界の侵襲性真菌症（IFD）感染診断試薬市場予測 2021年-2026年] (コード：LPI21MY9649)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の侵襲性真菌症（IFD）感染診断試薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の非侵襲的＆低侵襲皮膚閉鎖装置市場予測 2021年-2026年
    LPI21MY9150 / LP Information / 2021年5月 / LPインフォメーション社の「非侵襲的＆低侵襲皮膚閉鎖装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、接着剤系、マイクロアンカー系など、用途別には、子供（...According to this latest study, the 2021 growth of Non and Minimally Invasive Skin Closure will have significant change from previous year. By the most conservative estimates of global Non and Minimally Invasive Skin Closure market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Non and Minimally Invasive Skin Closure market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth...
  • 世界のハンセン病治療薬市場予測 2021年-2026年
    LPI21MY9549 / LP Information / 2021年5月 / LPインフォメーション社の「ハンセン病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クロファジミン、サリドマイド、その他など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。ハンセン病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハンセン病治療薬の世界市場概要（サマリー） ・ハンセン病治療薬の企業別販売量・売上 ・ハンセン病治療薬の企業別市場シェア ・ハンセン病治療薬の世界市場規模 2016年-2021年：種類別（クロファジミン、サリドマイド、その他） ・ハンセン病治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・ハンセン病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハンセン病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Hansen's Disease Therapeutics will have significant change from previous year. By the most conservative estimates of global Hansen's Disease Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hansen's Disease Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Hansen's Disease Therapeutics market by product type,...
  • 世界の侵襲性呼吸装置市場予測 2021年-2026年
    LPI21MY9258 / LP Information / 2021年5月 / LPインフォメーション社の「侵襲性呼吸装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ポータブル型、非ポータブル型など、用途別には、病院、診療所、家庭、その他などにセグメント区分してまとめました。侵襲性呼吸装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・侵襲性呼吸装置の世界市場概要（サマリー） ・侵襲性呼吸装置の企業別販売量・売上 ・侵襲性呼吸装置の企業別市場シェア ・侵襲性呼吸装置の世界市場規模 2016年-2021年：種類別（ポータブル型、非ポータブル型） ・侵襲性呼吸装置の世界市場規模 2016年-2021年：用途別（病院、診療所、家庭、その他） ・侵襲性呼吸装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・侵襲性呼吸装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Invasive Respiratory Devices will have significant change from previous year. By the most conservative estimates of global Invasive Respiratory Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Invasive Respiratory Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Respiratory Devices market by product type,...
  • 世界の手術感染管理用品市場予測 2021年-2026年
    LPI21MY9287 / LP Information / 2021年5月 / LPインフォメーション社の「手術感染管理用品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、手術用ドレープ、手術用ガウン、手術用キット、その他など、用途別には、病院、クリニック、外来手術センター、その他などにセグメント区分してまとめました。手術感染管理用品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・手術感染管理用品の世界市場概要（サマリー） ・手術感染管理用品の企業別販売量・売上 ・手術感染管理用品の企業別市場シェア ・手術感染管理用品の世界市場規模 2016年-2021年：種類別（手術用ドレープ、手術用ガウン、手術用キット、その他） ・手術感染管理用品の世界市場規模 2016年-2021年：用途別（病院、クリニック、外来手術センター、その他） ・手術感染管理用品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・手術感染管理用品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Surgical Infection Control Supplies will have significant change from previous year. By the most conservative estimates of global Surgical Infection Control Supplies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Surgical Infection Control Supplies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Infection Control Supplies...
  • 世界のDNAプローブ診断市場予測 2021年-2026年
    LPI21MY8936 / LP Information / 2021年5月 / LPインフォメーション社の「DNAプローブ診断の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DNAプローブ製品、標的配列直接検出、核酸増幅、DNAチップ遺伝子検出、DNAシーケンシング遺伝子検出など、用途別には、がん検診、感染症検査などにセグメント区分してまとめました。DNAプローブ診断のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・DNAプローブ診断の世界市場概要（サマリー） ・DNAプローブ診断の企業別販売量・売上 ・DNAプローブ診断の企業別市場シェア ・DNAプローブ診断の世界市場規模 2016年-2021年：種類別（DNAプローブ製品、標的配列直接検出、核酸増幅、DNAチップ遺伝子検出、DNAシーケンシング遺伝子検出） ・DNAプローブ診断の世界市場規模 2016年-2021年：用途別（がん検診、感染症検査） ・DNAプローブ診断の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・DNAプローブ診断のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of DNA Probe-based Diagnostic will have significant change from previous year. By the most conservative estimates of global DNA Probe-based Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the DNA Probe-based Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of DNA Probe-based Diagnostic market by product type,...
  • 世界のMRD（最小残存病変）検査市場予測 2021年-2026年
    LPI21MY9126 / LP Information / 2021年5月 / LPインフォメーション社の「MRD（最小残存病変）検査の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）など、用途別には、専門クリニック・病院、診断研究所、研究機関などにセグメント区分してまとめました。MRD（最小残存病変）検査のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・MRD（最小残存病変）検査の世界市場概要（サマリー） ・MRD（最小残存病変）検査の企業別販売量・売上 ・MRD（最小残存病変）検査の企業別市場シェア ・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：種類別（フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）） ・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：用途別（専門クリニック・病院、診断研究所、研究機関） ・MRD（最小残存病変）検査の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・MRD（最小残存病変）検査のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of MRD (Minimal Residual Disease) Testing will have significant change from previous year. By the most conservative estimates of global MRD (Minimal Residual Disease) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the MRD (Minimal Residual Disease) Testing market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of MRD...
  • 世界の糖尿病性眼疾患用装置市場予測 2021年-2026年
    LPI21MY8906 / LP Information / 2021年5月 / LPインフォメーション社の「糖尿病性眼疾患用装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、レーザー手術、硝子体切除術など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。糖尿病性眼疾患用装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・糖尿病性眼疾患用装置の世界市場概要（サマリー） ・糖尿病性眼疾患用装置の企業別販売量・売上 ・糖尿病性眼疾患用装置の企業別市場シェア ・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：種類別（レーザー手術、硝子体切除術） ・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・糖尿病性眼疾患用装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・糖尿病性眼疾患用装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Diabetic Eye Disease Devices will have significant change from previous year. By the most conservative estimates of global Diabetic Eye Disease Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Diabetic Eye Disease Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Eye Disease Devices...
  • 世界のゴーシェ病治療薬市場予測 2021年-2026年
    LPI21MY9538 / LP Information / 2021年5月 / LPインフォメーション社の「ゴーシェ病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬など、用途別には、I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病などにセグメント区分してまとめました。ゴーシェ病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴーシェ病治療薬の世界市場概要（サマリー） ・ゴーシェ病治療薬の企業別販売量・売上 ・ゴーシェ病治療薬の企業別市場シェア ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：種類別（酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬） ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：用途別（I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病） ・ゴーシェ病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴーシェ病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Gaucher Disease Drugs will have significant change from previous year. By the most conservative estimates of global Gaucher Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1292.3 million in 2019. Over the next five years the Gaucher Disease Drugs market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1326.1 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Gaucher Disease Drugs market by product type,...
  • 世界の生化学試薬市場予測 2021年-2026年
    LPI21MY9444 / LP Information / 2021年5月 / LPインフォメーション社の「生化学試薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クロマトグラフィー、質量分析、電気泳動など、用途別には、タンパク質合成・精製、遺伝子発現、DNA・RNA分析、薬物検査などにセグメント区分してまとめました。生化学試薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・生化学試薬の世界市場概要（サマリー） ・生化学試薬の企業別販売量・売上 ・生化学試薬の企業別市場シェア ・生化学試薬の世界市場規模 2016年-2021年：種類別（クロマトグラフィー、質量分析、電気泳動） ・生化学試薬の世界市場規模 2016年-2021年：用途別（タンパク質合成・精製、遺伝子発現、DNA・RNA分析、薬物検査） ・生化学試薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・生化学試薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Biochemical Reagent will have significant change from previous year. By the most conservative estimates of global Biochemical Reagent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Biochemical Reagent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Biochemical Reagent market by product type, application, key manufacturers and...
  • 世界の疾病検査用口腔液収集チューブ市場予測 2021年-2026年
    LPI21MY9167 / LP Information / 2021年5月 / LPインフォメーション社の「疾病検査用口腔液収集チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、唾液チューブ、口腔スポンジなど、用途別には、一般分析用、ゲノム分析用などにセグメント区分してまとめました。疾病検査用口腔液収集チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・疾病検査用口腔液収集チューブの世界市場概要（サマリー） ・疾病検査用口腔液収集チューブの企業別販売量・売上 ・疾病検査用口腔液収集チューブの企業別市場シェア ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：種類別（唾液チューブ、口腔スポンジ） ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：用途別（一般分析用、ゲノム分析用） ・疾病検査用口腔液収集チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・疾病検査用口腔液収集チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Oral Fluid Collection Tubes for Disease Testing will have significant change from previous year. By the most conservative estimates of global Oral Fluid Collection Tubes for Disease Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Oral Fluid Collection Tubes for Disease Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market...

    • ◆H&Iグローバルリサーチのお客様（例）◆